drugset / Trial / NCT04420585

Desmopressin for Bedwetting in Children With SCD

NCT04420585

Phase 4 Terminated 8 enrolled Montefiore Medical Center
NaSingle-groupOpen-labelTreatment

Summary

This study assesses if using the medication desmopressin will decrease nightime bedwetting in children with sickle cell disease.

Timeline

Start
2020-07-07
Primary completion
2023-06-12
Completion
2023-06-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Desmopressin Peptide 0.4 mg Oral